Knowledge is power with new cancer test

Knowledge is power with new cancer test
David Corr, chief executive, Atturos Pic: Liam Blake

Medtech start-up Atturos is preparing to bring to market a blood test that could help men diagnosed with prostate cancer avoid undergoing unnecessary surgery. “The lead product we have in development is a test for men who have been diagnosed with low to intermediate prostate cancer,” said David Corr, chief executive of Atturos. “They have to decide whether to opt for surgery and radiotherapy or go on to an active surveillance programme. These treatment options...

Subscribe from just 1€

Exclusive offers

Choose the subscription that is right for you

Monthly Subscription


For the first month

€19.99 Monthly Thereafter

Subscribe today

Cancel anytime

Annual Subscription


For the first year

€199.99 annually thereafter

Subscribe today

Cancel anytime

Quarterly Subscription


For the first 90 days

€55.00 quarterly Thereafter

Subscribe today

Cancel anytime

These offers are not available for current subscribers. Offers and pricing are subject to change without notice.

Terms & Conditions Apply

Please Subscribe or Log in to continue

Subscribe Login

Related Articles

More from The Business Post